Topics

Se-cure Pharmaceuticals Company Profile

21:57 EDT 21st September 2019 | BioPortfolio

Founded in 1997, Se-cure Pharmaceuticals Ltd. is a clinical stage technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions, derived from botanical sources. Implementing proprietary botanical drug development and scaling technologies, Se-cure is able to introduce novel biochemical agents characterized by functionally selective mechanisms of action in the target tissues.


News Articles [1335 Associated News Articles listed on BioPortfolio]

A Talk With the CEO of CURE Pharmaceutical

In the cannabis sector of drug development, there is a movement happening. And Rob Davidson, chief executive officer of CURE Pharmaceuticals is making sure his company is ready for the next steps.

CURE Pharmaceutical Snags DEA License to Manufacture Pharmaceuticals from Cannabis

Shares of CURE Pharmaceutical jumped more than 15 percent Monday ahead of news that the company became the first and only oral thin film company to gain a license from the U.S. Drug Enforcement Agency...

Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes

Vertex Pharmaceuticals announced that it plans to acquire an ambitious startup for $950 million, betting the company's early-stage science could lead to a functional cure for type 1 diabetes.

CURE Natural Aqua Gel: Japanese Skincare with a Cult Following

LAS VEGAS (PRWEB) July 23, 2019 Cure Natural Aqua Gel is a water-based exfoliant from Japan that was first launched in 2003. Cure is...

CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant

OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement A...

CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole ...

OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) Read more...

The Cure at Glastonbury 2019 review – still the world’s most reluctant pop stars – The Guardian

The Cure at Glastonbury 2019 review – still the world's most reluctant pop stars The GuardianThe Cure review, Pyramid Stage, Glastonbury: Robert Smith lets 41 years of rocking speak for itself Tel...

Vertex snaps up company working on cure for Type 1 diabetes

Vertex Pharmaceuticals announced this week that it is buying Semma Therapeutics for $950 million in cash.

PubMed Articles [331 Associated PubMed Articles listed on BioPortfolio]

A cure for type 2 diabetes: fact or fiction?

In the world of type 2 diabetes, the word 'cure' generates strong negative feelings in some professionals working in the field, because they doubt the concept of a cure for this condition [1]. There i...

A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience.

The primary end-point was to evaluate the cure fraction. Secondary end-points were to investigate the time to cure, the excess of death risk, the probability of cure and the factors related to these p...

Major patterns of cancer cure: Clinical implications.

This review aimed to classify major patterns of cancer cure and discuss clinical implications. Patterns of cancer cure were identified, in terms of long-term survival and life expectancy, by means of ...

Time-to-cure and cure proportion in solid cancers in France. A population based study.

In cancer care, the cure proportion (P) and time-to-cure (TTC) are important indicators for practitioners, patients, and healthcare policy makers. The recent definition of TTC as the time at which the...

Mytilidae as model organisms in the marine ecotoxicology of pharmaceuticals - A review.

Growing production and consumption of pharmaceuticals is a global problem. Due to insufficient data on the concentration and distribution of pharmaceuticals in the marine environment, there are no app...

Clinical Trials [923 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Towards a Functional Cure for HBV - The COMMIT Cohort Study

Hepatitis B virus (HBV) infection can be treated, but therapy is usually lifelong and has side effects, so a cure for HBV is a critical endpoint. This study examines the key steps to HBV c...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1641 Associated Companies listed on BioPortfolio]

Se-cure Pharmaceuticals

Founded in 1997, Se-cure Pharmaceuticals Ltd. is a clinical stage technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions, derived ...

Standup for the Cure

Standup for the Cure is a Non-Profit Corporation formed in 2012 which raised more than $60,000 at its inaugural May event for the Orange County Affiliate of Susan G. Komen For The...

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis, www.acceleratedcure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its cause...

P‐Cure Ltd.

P‐Cure develops advanced solutions that help bring proton therapy to routine clinical practice. The P-Cure system provides an integrated solution with volumetric imaging, pat...

CURE

CURE is the educational and business support network organization for bioscience in Connecticut, with over 100 members. Its mission is to build networks and critical mass for the industry within the s...

More Information about "Se-cure Pharmaceuticals" on BioPortfolio

We have published hundreds of Se-cure Pharmaceuticals news stories on BioPortfolio along with dozens of Se-cure Pharmaceuticals Clinical Trials and PubMed Articles about Se-cure Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Se-cure Pharmaceuticals Companies in our database. You can also find out about relevant Se-cure Pharmaceuticals Drugs and Medications on this site too.

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record